# Kymera Therapeutics, Inc.: Form DEF 14A, filed Apr 29, 2026

- Company: [Kymera Therapeutics, Inc.](/companies/kymr.md) (CIK 1815442)
- Form: DEF 14A
- Filed: 2026-04-29
- Accepted by EDGAR: Apr 29, 2026, 16:05 ET
- Period: 2026-06-24
- Accession: 0001193125-26-191495
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1815442/000119312526191495/kymr-20260428.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815442/000119312526191495/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815442/000119312526191495/kymr-20260428.htm

Filed Apr 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-191495. Last ingested by Listed: Oct 29, 2026, 07:17 ET. No prices; not investment advice.
